Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous paravertebral wound catheter ropivacaine after lumbar fusion
2008-005696-10Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine and isotonic saline in lumbosacral disc disease (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Pain score at 2 months postoperatively. Started Sep 2008; status: active.
02
Drugs
ropivacaineisotonic saline
03
Conditions
lumbosacral disc disease
Beyond the preview
Go deeper on 2008-005696-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005696-10.